ORIC PHARMACEUTICALS

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

06 Oct 2023 16:30:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference

20 Sep 2023 16:30:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 Sep 2023 16:30:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

30 Aug 2023 16:30:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates

10 Aug 2023 16:05:03 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

04 Aug 2023 16:30:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals Announces $85 Million Private Placement Financing

26 Jun 2023 08:30:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02 Jun 2023 16:15:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conference

31 May 2023 16:10:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates

08 May 2023 16:05:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

05 May 2023 16:15:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the H.C. Wainwright BioConnect Investor Conference

25 Apr 2023 16:30:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting

18 Apr 2023 16:15:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates

16 Mar 2023 16:05:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals Announces Multiple Presentations at the 2023 American Association for Cancer Research (AACR) Annual Meeting

14 Mar 2023 16:30:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the Oppenheimer 33rd Annual Healthcare Conference

06 Mar 2023 16:15:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 Feb 2023 16:30:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

01 Feb 2023 16:30:00 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones

09 Jan 2023 08:00:01 By Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference

03 Jan 2023 16:30:00 By Nasdaq GlobeNewswire